2024
|
P/S
|
Chemicals for use in industry and science; biological preparations for use in industry and scienc... |
|
P/S
|
Chemicals for use in industry and science; biological
preparations for use in industry and scien... |
2023
|
P/S
|
Scientific research and development; pharmaceutical product development; consultancy pertaining t... |
|
Invention
|
Methods of isolating anti-ligands. The present invention relates to improved methods of isolating... |
|
Invention
|
Combination of a fcyrllb- and a tumor antibody for use in the treatment of an fcyriib-negative ca... |
2022
|
Invention
|
Novel combinations of antibodies and uses thereof.
The present invention generally relates to a ... |
|
Invention
|
Novel combinations of antibodies and uses thereof. The present invention generally relates to a c... |
|
Invention
|
Novel antibodies and combined use of a treg depleting antibody and an immunostimulatory antibody.... |
|
Invention
|
Novel combinations of antibodies and uses thereof.
The present invention generally relates to an... |
|
Invention
|
Novel combinations of antibodies and uses thereof. The present disclosure generally relates to an... |
2021
|
Invention
|
Improving antibody tolerability associated with intravenous administration.
The present inventio... |
|
Invention
|
Model for prediction of tolerability issues in connection with intravenous administration of ther... |
|
Invention
|
Improving antibody tolerability associated with intravenous administration. The present invention... |
|
Invention
|
Improving antibody tolerabilty associated with intravenous administration. Also described herein ... |
|
P/S
|
Chemical preparations, namely, antibodies and antibody genes stored within phages to be used in s... |
|
Invention
|
Lilrb3 antibody molecules and uses thereof.
Described are anti-LILRB3 antibody molecules, such a... |
|
Invention
|
Lilrb3 antibody molecules and uses thereof. Described are anti-LILRB3 antibody molecules, such as... |
2020
|
Invention
|
Tetravalent antibody molecules. 222 fragments. |
|
Invention
|
Combination of anti-fgfr4-antibody and bile acid sequestrant. The present invention relates to th... |
|
Invention
|
Antibody combinations for treatment of cancer in specific patients.
Described is the combined us... |
|
Invention
|
Antibody combinations for treatment of cancer in specific patients. Described is the combined use... |
2019
|
Invention
|
Novel agonistic anti tnfr2 antibody molecules.
Described are novel antagonistic antibody molecul... |
|
Invention
|
Agonistic anti tnfr2 antibody molecules. Described are novel antibody molecules that specifically... |
|
Invention
|
Novel agonistic antibody molecules. Described are novel antibody molecules that specifically bind... |
|
Invention
|
Novel agonistic anti tnfr2 antibody molecules. Described are novel antibody molecules that specif... |
|
Invention
|
Novel antagonistic anti tnfr2 antibody molecules. Described are novel antagonistic antibody molec... |
|
Invention
|
Novel antibodies and nucleotide sequences, and uses thereof.
Described are novel anti-CTLA-4 ant... |
|
Invention
|
Anti-ctla-4 antibodies and their use in depleting ctla-4-positive cells. Described are novel anti... |
|
Invention
|
Novel antibodies and nucleotide sequences, and uses thereof. Described are novel anti-CTLA-4 anti... |
|
Invention
|
Novel combination and use of antibodies. Described is the use of a first antibody molecule that s... |
2018
|
Invention
|
Novel combination and use of antibodies.
Described is the use of a first antibody molecule that ... |
2017
|
Invention
|
Use of antibodies against icam-1 in combination with an anti cancer drug in the treatment of pati... |
|
Invention
|
Combination of human anti-fgfr4 antibody and sorafenib. The present invention relates to the medi... |
2016
|
Invention
|
Method for screening anti-ligand libraries for identifying anti-ligands specific for differential... |
|
Invention
|
Use of antibodies against icam-1 in the treatment of patients with relapsed cancer.
There is pro... |
2015
|
Invention
|
Human anti-fgfr4 antibody. The present invention relates to novel antibodies against the FGF rece... |
|
Invention
|
Medicaments, uses and methods.
Description of a composition comprising an antibody molecule and ... |
|
Invention
|
Medicaments, uses and methods. Description of a composition comprising an antibody molecule and a... |
2014
|
Invention
|
Biological materials and uses thereof. The invention provides binding molecules, including antibo... |
2012
|
Invention
|
Anti-icam-1 antibodies to treat multiple-myeloma related disorders.
The invention relates to the... |
|
Invention
|
Screening methods and uses thereof. The present invention relates to improved screening methods a... |
2008
|
P/S
|
Chemicals and chemical products, namely, proteins for biotechnological purposes; chemical product... |
2004
|
P/S
|
Scientific research and development services; drug discovery services; screening genes; identifyi... |
2001
|
P/S
|
[ Chemicals for scientific, laboratory or medical research; chemicals for use in the manufacture ... |
|
P/S
|
Chemicals for analytical, diagnostic and immunological purposes and laboratory use; chemicals for... |
2000
|
P/S
|
proteins for scientific and research use; [ chemical preparations for use in protein analysis; ] ... |
1999
|
P/S
|
Chemical preparations for analytical and diagnostic purposes and laboratory use; chemical prepara... |